Nonalcoholic steatohepatitis recurrence after liver transplant
Authors:
Open Access
- 1 April 2020
- journal article
- review article
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 5, 24
Abstract
Nonalcoholic steatohepatitis (NASH) is the fastest growing indication for liver transplant (LT)worldwide and is deemed to be the foremost indication in the near future. Recurrence of NASH can occur post LT and has been observed to be a common phenomenon. Baseline metabolic co-morbidities and worsening of metabolic profile post LT are the principal drivers of NASH recurrence. Liver biopsy remains the gold standard for establishing the diagnosis. However, noninvasive methods including transient elastography (TE) and magnetic resonance imaging (MRI) seem to be promising. The implications of recurrent NASH on post LT outcomes, graft steatosis, progression to fibrosis, overall survival, and cardiovascular associations warrant careful evaluation. Control of metabolic parameters and weight gain along with tailored immunosuppression remain the cornerstone of management. Extrapolation of the ever-increasing armamentarium of NASH pharmacotherapy specifically in this population of recurrent NAFLD remains a challenge for the future.Keywords
This publication has 30 references indexed in Scilit:
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United StatesGastroenterology, 2011
- NAFLD Recurrence in Liver Transplant RecipientsTransplantation, 2011
- Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver diseaseLiver Transplantation, 2009
- Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis CirrhosisLiver Transplantation, 2009
- A Randomized Trial of Exercise and Dietary Counseling After Liver TransplantationAmerican Journal of Transplantation, 2006
- Weight gain and obesity after liver transplantationTransplant International, 2005
- Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis and Orthotopic Liver TransplantationAmerican Journal of Transplantation, 2004
- Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosisLiver Transplantation, 2001
- LONG-TERM RESULTS OF LIVER TRANSPLANTATION IN PATIENTS 60 YEARS OF AGE AND OLDER12Transplantation, 2000
- EXCESSIVE WEIGHT GAIN AFTER LIVER TRANSPLANTATIONTransplantation, 1991